RecruitingNCT02055105

Modulation of Molecular Fingerprinting in Pediatric Sepsis


Sponsor

Phoenix Children's Hospital

Enrollment

50 participants

Start Date

Mar 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.


Eligibility

Min Age: 1 YearMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called miRNA in Sepsis for people with systemic inflammatory response syndrome. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 1 Year to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREmiRNA in Sepsis

miRNA in Sepsis


Locations(2)

Phoenix Children's Hospital

Phoenix, Arizona, United States

Phoenix Children's Hospital

Phoenix, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02055105


Related Trials